X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Afadin-deficient mice, whose outer-retinal lamination and photoreceptor synapses are severely disrupted, nonetheless partially retain retinal neural circuits and visual function.
Intraocular foreign body removal visual outcome may be affected by race, according to a review of IRIS Registry data.
Pars plana vitrectomy is a viable option to correct an epiretinal membrane in patients with glaucoma, even if it includes ILM peeling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback